Concepedia

Fangxian Sun

FS

Statistics

Publications

27

Citations

4.4K

H-Index

25

Active since

2000

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Sanofi (United States)

Sanofi (France)

AVEO Oncology (United States)

AntiCancer (United States)

Fangxian Sun is an author at Genomics Institute of the Novartis Research Foundation specializing in medicine, oncology, and pharmacology.

Publications per year

2000–2021

27

Publications

27

Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974

Jun Liu, Shifeng Pan, Mindy H. Hsieh et al. · Proceedings of the National Academy of Sciences · 2013 · 835 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

Jianming Zhang, Francisco Adrián, Wolfgang Jahnke et al. · Nature · 2010 · 599 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases

Meng Yang, Eugene Baranov, Ping Jiang et al. · Proceedings of the National Academy of Sciences · 2000 · 513 citations

Medicine, Molecular Biology, Oncology +14

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK

Anna Galkin, Jonathan S. Melnick, Sung Joon Kim et al. · Proceedings of the National Academy of Sciences · 2006 · 377 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist

Shifeng Pan, Xu Wu, Jiqing Jiang et al. · ACS Medicinal Chemistry Letters · 2010 · 328 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 27